Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Poultry Vaccines Market by Vaccine type, Formulation, Application: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis and Forecast 2017 to 2024


 

Available formats:    

StumbleUponEmail

Global Poultry Vaccines Market: By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2024

 

Poultry Vaccines Market Dynamics

 

Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat, rise in number of poultry industries, grow in R&D for the innovation of newer vaccines, and rise in prevalence of various infectious diseases are anticipated to fuel poultry vaccines market over the forecast period.

 

Furthermore, government initiations for protecting the animal health, rise in veterinary healthcare expenditure, and vaccination programs organized by the companies are expected to boost the market over the forecast period. However, stringent regulatory guidelines for the vaccine approval, adverse effects associated with vaccines, high R&D expenditure, and increase in adoption of vegetarian food may restrain the growth of market over the forecast timeframe.

 

Poultry Vaccines Market Segmentation

The market is segmented on the basis of vaccine type, formulation, application, and region

Based on the vaccine type, the market is segmented into the following:

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines

Based on the formulation, the market is segmented into the following:

  • Dry Form (Duct) Vaccines
  • Liquid Vaccines
  • Freeze Dried Vaccines

Based on the application, the market is segmented into the following:

  • Marek’s Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Others

Based on the region, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Poultry Vaccines Market Regional Analysis

Geographically, global poultry vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America poultry vaccines market has a significant share owing to rise in demand for healthy meat, increase in R&D for the innovation of newer vaccines, and rise in veterinary healthcare expenditure. Europe poultry vaccines market is growing due to launching of newer vaccines into market, rise in prevalence of poultry diseases, and grow in per capita income.

 

Asia Pacific poultry vaccines market is expected to exhibit significant growth rate over the forecast period owing to increase in poultry production, government vaccination programs, and rise in population demand for healthy meat in China and India. Latin America poultry vaccines market growing due to adoption of newer vaccines, economic growth, and increase in consumption of poultry meat are propel the market. Middle East and Africa poultry vaccines market is driven by expansion of business by companies, rise in prevalence of zoonotic diseases, and increase in awareness about the vaccines expected to upsurge the revenue of market.

 

Competition Assessment

  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Indovax Pvt. Ltd. (India)
  • Hester Biosciences Limited. (India)
  • Zydus AHL (India)

 

Notable Market Developments

  • In November 2017, French firm Ceva Sante Animale launched two new poultry vaccines in India through joint venture with Ceva Polchem for the treatment of Gumboro disease and Ranikhet disease.

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

1. Executive Summary
 
2. Global Poultry Vaccines Market Introduction

      2.1. Global Poultry Vaccines Market – Taxonomy
      2.2. Global Poultry Vaccines Market –Definitions
            2.2.1. Vaccine Type
            2.2.2. Application
 
3. Global Poultry Vaccines Market Dynamics
      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Poultry Vaccines Market Dynamic Factors – Impact Analysis
      3.6. Global Poultry Vaccines Market – Regulations
            3.6.1. U.S.
            3.6.2. Europe
 
4. Global Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
      4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      4.3. Market Opportunity Analysis
 
5. Global Poultry Vaccines Market Analysis, By Vaccine Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      5.1. Inactivated Vaccines
            5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. Live Attenuated Vaccines
            5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.2.3. Market Opportunity Analysis
      5.3. Recombinant Vaccines
            5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.3.3. Market Opportunity Analysis
 
6. Global Poultry Vaccines Market Analysis, By Application, 2013 – 2017 and Forecast, 2018 – 2024
      6.1. Marek’s Disease
            6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Newcastle Disease
            6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Infectious Bursal Disease
            6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.3.3. Market Opportunity Analysis
      6.4. Infectious Bronchitis
            6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.4.3. Market Opportunity Analysis
      6.5. Others
            6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.5.3. Market Opportunity Analysis
 
7. Global Poultry Vaccines Market Analysis, By Formulation, 2013 – 2017 and Forecast, 2018 – 2024
      7.1. Dry Form (Duct) Vaccines
            7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Liquid Vaccines
            7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Freeze Dried Vaccines
            7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis
 
8. Global Poultry Vaccines Market Analysis, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      8.1. North America
            8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.1.3. Market Opportunity Analysis
      8.2. Europe
            8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.2.3. Market Opportunity Analysis
      8.3. Asia-Pacific
            8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.3.3. Market Opportunity Analysis
      8.4. Latin America
            8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.4.3. Market Opportunity Analysis
      8.5. Middle East and Africa
            8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.5.3. Market Opportunity Analysis
      8.6. Global Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2018 – 2024
 
9. North America Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      9.1. Vaccine Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            9.1.1. Inactivated Vaccines
            9.1.2. Live Attenuated Vaccines
            9.1.3. Recombinant Vaccines
      9.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Marek’s Disease
            9.2.2. Newcastle Disease
            9.2.3. Infectious Bursal Disease
            9.2.4. Infectious Bronchitis
            9.2.5. Others
      9.3. Formulation Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Dry Form (Duct) Vaccines
            9.3.2. Liquid Vaccines
            9.3.3. Freeze Dried Vaccines
      9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            9.4.1. U.S.
            9.4.2. Canada
      9.5. North America Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024
      9.6. North America Poultry Vaccines Market Dynamics – Trends
 
10. Europe Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      10.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            10.1.1. Germany
            10.1.2. UK
            10.1.3. France
            10.1.4. Spain
            10.1.5. Italy
            10.1.6. Russia
            10.1.7. Poland
            10.1.8. Rest of Europe
      10.2. Europe Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024
      10.3. Europe Poultry Vaccines Market Dynamics – Trends
 
11. Asia-Pacific Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      11.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            11.1.1. Japan
            11.1.2. China
            11.1.3. India
            11.1.4. ASEAN
            11.1.5. Australia & New Zealand
            11.1.6. Rest of Asia-Pacific
      11.2. Asia-Pacific Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024
      11.3. Asia-Pacific Poultry Vaccines Market Dynamics – Trends
 
12. Latin America Poultry Vaccines Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      12.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            12.1.1. Brazil
            12.1.2. Mexico
            12.1.3. Argentina
            12.1.4. Venezuela
            12.1.5. Rest of Latin America
      12.2. Latin America Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024
      12.3. Latin America Poultry Vaccines Market Dynamics – Trends
 
13. Middle East and Africa Poultry Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      13.1. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            13.1.1. Gulf Cooperation Council (GCC) Countries
            13.1.2. Israel
            13.1.3. South Africa
            13.1.4. Rest of MEA
      13.2. MEA Poultry Vaccines Market – Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2018 – 2024
      13.3. MEA Poultry Vaccines Market Dynamics – Trends
 
14. Competition Landscape
      14.1. Strategic Dashboard of Top Market Players
      14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
            14.2.2. Merck & Co. Inc. (U.S)
            14.2.3. Boehringer Ingelheim Vetmedica (Germany)
            14.2.4. Elanco (U.S.)
            14.2.5. Bayer Animal Health (Germany)
            14.2.6. Ceva Sante Animale (France)
            14.2.7. Indovax Pvt. Ltd. (India)
            14.2.8. Hester Biosciences Limited. (India)
            14.2.9. Zydus AHL (India)
 
15. Research Methodology
 
16. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553